Article
PPAR gamma activation protects the brain against microvascular dysfunction in sepsis
Registro en:
ARAÚJO, C. V. et al. PPAR gamma activation protects the brain against microvascular dysfunction in sepsis. Microvascular Research, v.84, n.2, p.218-221, 2012.
0026-2862
10.1016/j.mvr.2012.05.006
1095-9319
Autor
Araújo, C. V.
Estato, V.
Tibiriçá, E.
Bozza, P. T.
Faria Neto, H. C. Castro
Silva, A. R.
Resumen
Sepsis is a severe disorder characterized by systemic inflammatory responses in the presence of an infection and may progress to multiple organ dysfunction and death. Alterations in cerebral microcirculation fulfill a crucial role in the pathogenesis of severe sepsis, and include a decrease in capillary density and disturbances in leukocyte movement along capillaries. Nevertheless, the mechanisms involved in sepsis-associated cerebral microcirculatory alterations have so far not been defined. We investigated the effect of the peroxisome proliferator-activated receptor gamma (PPARγ) selective agonist rosiglitazone on leukocyte/endothelial cell interaction and functional capillary density in the brain in the cecal ligation and puncture (CLP) model of sepsis. Anti-inflammatory effects of rosiglitazone on the cerebral microcirculation were marked. Functional capillary density increased and leukocyte rolling and adhesion were decreased in animals submitted to CLP and treated with rosiglitazone. Our data provide evidence for involvement of PPARγ activation in leukocyte-endothelium interactions and alterations in capillary density. Improved cerebral perfusion in animals treated with rosiglitazone, suggests that PPARγ activation is protective against cerebral microvascular dysfunction in sepsis. 2030-01-01